226 related articles for article (PubMed ID: 24222348)
1. Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study.
Lowe G; Woodward M; Hillis G; Rumley A; Li Q; Harrap S; Marre M; Hamet P; Patel A; Poulter N; Chalmers J
Diabetes; 2014 Mar; 63(3):1115-23. PubMed ID: 24222348
[TBL] [Abstract][Full Text] [Related]
2. [CRP and micro-albumin: new markers of cardiovascular risk in type 2 diabetes].
El Oudi M; Aouni Z; Ouertani H; Mazigh C; Nsiri B; Zidi B; Machghoul S
Ann Cardiol Angeiol (Paris); 2011 Aug; 60(4):207-10. PubMed ID: 21571249
[TBL] [Abstract][Full Text] [Related]
3. The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus.
Blomster JI; Chow CK; Zoungas S; Woodward M; Patel A; Poulter NR; Marre M; Harrap S; Chalmers J; Hillis GS
Diabetes Obes Metab; 2013 Nov; 15(11):1008-12. PubMed ID: 23675676
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.
Linnemann B; Voigt W; Nobel W; Janka HU
Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):127-34. PubMed ID: 16636979
[TBL] [Abstract][Full Text] [Related]
5. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
6. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
Grauslund J
Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
[TBL] [Abstract][Full Text] [Related]
7. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Thorand B; Baumert J; Kolb H; Meisinger C; Chambless L; Koenig W; Herder C
Diabetes Care; 2007 Apr; 30(4):854-60. PubMed ID: 17392546
[TBL] [Abstract][Full Text] [Related]
9. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
Mora S; Rifai N; Buring JE; Ridker PM
Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
[TBL] [Abstract][Full Text] [Related]
11. Inflammation biomarkers and near-term death in older men.
Jenny NS; Yanez ND; Psaty BM; Kuller LH; Hirsch CH; Tracy RP
Am J Epidemiol; 2007 Mar; 165(6):684-95. PubMed ID: 17215383
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.
Yu HI; Sheu WH; Song YM; Liu HC; Lee WJ; Chen YT
Diabet Med; 2004 Apr; 21(4):336-41. PubMed ID: 15049935
[TBL] [Abstract][Full Text] [Related]
13. Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.
Libra M; Signorelli SS; Bevelacqua Y; Navolanic PM; Bevelacqua V; Polesel J; Talamini R; Stivala F; Mazzarino MC; Malaponte G
J Clin Pathol; 2006 Feb; 59(2):211-5. PubMed ID: 16443741
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis.
Ranjit N; Diez-Roux AV; Shea S; Cushman M; Seeman T; Jackson SA; Ni H
Arch Intern Med; 2007 Jan; 167(2):174-81. PubMed ID: 17242319
[TBL] [Abstract][Full Text] [Related]
15. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study.
Welsh P; Woodward M; Rumley A; Lowe G
Br J Haematol; 2008 Jun; 141(6):852-61. PubMed ID: 18371109
[TBL] [Abstract][Full Text] [Related]
16. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
[TBL] [Abstract][Full Text] [Related]
17. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
Ridker PM; Hennekens CH; Buring JE; Rifai N
N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study.
Best LG; Zhang Y; Lee ET; Yeh JL; Cowan L; Palmieri V; Roman M; Devereux RB; Fabsitz RR; Tracy RP; Robbins D; Davidson M; Ahmed A; Howard BV
Circulation; 2005 Aug; 112(9):1289-95. PubMed ID: 16116058
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
Luc G; Bard JM; Juhan-Vague I; Ferrieres J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetiere P;
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1255-61. PubMed ID: 12775578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
